Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Dose ranging safety and efficacy studies to advance novel mechanism-of-action small molecule leads to treat obesity-linked type 2 diabetes
Hommel, Jonathan
(PI)
Pharmacology & Toxicology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/1/18
→
8/31/19
Funding
Ridgeline Therapeutics, LLC ( Award #1R41DK11905201):
$130,268.00
View all
View less